{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-11-27T12:24:26.051874+00:00",
  "news": [
    {
      "title": "Where Will Vertex Pharmaceuticals Be in 5 Years - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMilAFBVV95cUxORjVqc3Y2VWFFZ3VOZy1rbDBMUzhWcHY0WDNuRGt6aVBxQlRBM01fcjhlRHVqdjFKc3BERUxMVzFIdFVMWHJxV1diLWhTN0JPdjVuSlRhSkx2eWQ0VC1ZSjhmZlMwX0ozU0g5OXNpZFRIWkJ6TWZIbXNtTnZrNVZKTVAzU0piMDQ2SThHQjN4UWd5YXhr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilAFBVV95cUxORjVqc3Y2VWFFZ3VOZy1rbDBMUzhWcHY0WDNuRGt6aVBxQlRBM01fcjhlRHVqdjFKc3BERUxMVzFIdFVMWHJxV1diLWhTN0JPdjVuSlRhSkx2eWQ0VC1ZSjhmZlMwX0ozU0g5OXNpZFRIWkJ6TWZIbXNtTnZrNVZKTVAzU0piMDQ2SThHQjN4UWd5YXhr?oc=5\" target=\"_blank\">Where Will Vertex Pharmaceuticals Be in 5 Years</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2025-11-27T11:31:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Where Will Vertex Pharmaceuticals Be in 5 Years - AOL.com",
      "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxOelVVaVBOblZ5MDVPamdGOWlMcHFsNnBxZFFvc2ZJeW81MUFGa0R0VzZSOVJ1TDRFQjdqdG1hZTlGMmFSWlFzNTRjMDJFbUloNTZBRFk0cVJsSl9fc0M3T3REbTNuME8za0ZLSVgtZWZid21HTm9KT3JYZ3NBVGJlUGdDZmhKcTA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxOelVVaVBOblZ5MDVPamdGOWlMcHFsNnBxZFFvc2ZJeW81MUFGa0R0VzZSOVJ1TDRFQjdqdG1hZTlGMmFSWlFzNTRjMDJFbUloNTZBRFk0cVJsSl9fc0M3T3REbTNuME8za0ZLSVgtZWZid21HTm9KT3JYZ3NBVGJlUGdDZmhKcTA?oc=5\" target=\"_blank\">Where Will Vertex Pharmaceuticals Be in 5 Years</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AOL.com</font>",
      "published": "2025-11-27T12:13:01+00:00",
      "source": "AOL.com"
    },
    {
      "title": "What Do Analysts Think About Vertex Pharmaceuticals (VRTX)? - Finviz",
      "link": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQNmNkZl9zeWdweEpNTjhvMFVVQ3RQV3FaRWRYNEtmVXBEc1BjS2o2dUg4Z3lFNGtEYlNUUkg2bHBlTW13SmdxV2FrNXI2VTNnaElTa0xTVk0zckctVHFjaUxFRXcyd25yYURBWmlNTWxhSUtqS3BnYXd1Z2EtajRZd2dfVS1iNWhhTjdhMkJvZE8?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikAFBVV95cUxQNmNkZl9zeWdweEpNTjhvMFVVQ3RQV3FaRWRYNEtmVXBEc1BjS2o2dUg4Z3lFNGtEYlNUUkg2bHBlTW13SmdxV2FrNXI2VTNnaElTa0xTVk0zckctVHFjaUxFRXcyd25yYURBWmlNTWxhSUtqS3BnYXd1Z2EtajRZd2dfVS1iNWhhTjdhMkJvZE8?oc=5\" target=\"_blank\">What Do Analysts Think About Vertex Pharmaceuticals (VRTX)?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Finviz</font>",
      "published": "2025-11-26T21:13:54+00:00",
      "source": "Finviz"
    },
    {
      "title": "Vertex Pharmaceuticals (VRTX) Stock Trades Up, Here Is Why - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijwFBVV95cUxORE1yTDZhZ1V3MXZ1QjhtTHZfRkluQ0dzbmNuRzY2OXNZWDBCeUJkUUNhXzNTVFo4LUtHcU5McjYtazFSZks4bVc0TTBpNDlWaWhTWUxFQ2VVNGhrZzFfWFdlTTNPVkVxRGJtRE9GaEk4YmRvV0M0aWcydDNaTzcxQUttSXktVU43emtoUkNkRQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijwFBVV95cUxORE1yTDZhZ1V3MXZ1QjhtTHZfRkluQ0dzbmNuRzY2OXNZWDBCeUJkUUNhXzNTVFo4LUtHcU5McjYtazFSZks4bVc0TTBpNDlWaWhTWUxFQ2VVNGhrZzFfWFdlTTNPVkVxRGJtRE9GaEk4YmRvV0M0aWcydDNaTzcxQUttSXktVU43emtoUkNkRQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX) Stock Trades Up, Here Is Why</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-21T23:56:16+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "A Look at Vertex Pharmaceuticals’s Valuation After Discontinuing Experimental Pain Drug Development - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">A Look at Vertex Pharmaceuticals’s Valuation After Discontinuing Experimental Pain Drug Development</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-11-26T04:46:35+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Scotiabank Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX) - The Globe and Mail",
      "link": "https://news.google.com/rss/articles/CBMi6wFBVV95cUxPZ3NZRlRXNlhSZkZqdWtaOVBWWXBjeVNfNkg5X3pWNDBud0JfcFd5SE1MZEpDSnRQdi1FV3FBZzhuM2NSNVJiUmRjdXN4WEM1dWtvVmJDR3U1R3BfYWphbWpIUnBVN0MyUHdCdFVkMjkzRjdlWnJxWXBIUVlVME40OTdCa3pMWHNkSl9Qdkl4UFNkYmFkLWZKNTZVM3ZtLTM3RGMzNkNlVmI0cm9sTnp6SzBwbS05QlQzZXZTa0FubmcyS2JIU0VLWFctVVQycjZxOThGeEVZby04V1dRdWY1b3ZOaWlEdXU1R3Fv?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi6wFBVV95cUxPZ3NZRlRXNlhSZkZqdWtaOVBWWXBjeVNfNkg5X3pWNDBud0JfcFd5SE1MZEpDSnRQdi1FV3FBZzhuM2NSNVJiUmRjdXN4WEM1dWtvVmJDR3U1R3BfYWphbWpIUnBVN0MyUHdCdFVkMjkzRjdlWnJxWXBIUVlVME40OTdCa3pMWHNkSl9Qdkl4UFNkYmFkLWZKNTZVM3ZtLTM3RGMzNkNlVmI0cm9sTnp6SzBwbS05QlQzZXZTa0FubmcyS2JIU0VLWFctVVQycjZxOThGeEVZby04V1dRdWY1b3ZOaWlEdXU1R3Fv?oc=5\" target=\"_blank\">Scotiabank Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Globe and Mail</font>",
      "published": "2025-11-26T13:30:53+00:00",
      "source": "The Globe and Mail"
    },
    {
      "title": "TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals - Time Magazine",
      "link": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQVkY3MnJaQ3p3Mk5LZGVBRXhDY0ZmaF9CS21MZWJSb01RRTNUN0JHUE9lTGRrckh6QnkxUGhXcm1yNk81WmM5aVdxZVdTdEFTMTBaN0E0MndpNHRLWjBJd2RrZ09JT3ZDaE04d21ucmVkcnl4aGFIcFlaN1QxcGtiT1lYQ2ppX202b2pr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQVkY3MnJaQ3p3Mk5LZGVBRXhDY0ZmaF9CS21MZWJSb01RRTNUN0JHUE9lTGRrckh6QnkxUGhXcm1yNk81WmM5aVdxZVdTdEFTMTBaN0E0MndpNHRLWjBJd2RrZ09JT3ZDaE04d21ucmVkcnl4aGFIcFlaN1QxcGtiT1lYQ2ppX202b2pr?oc=5\" target=\"_blank\">TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Time Magazine</font>",
      "published": "2025-06-26T07:00:00+00:00",
      "source": "Time Magazine"
    },
    {
      "title": "Vertex Pharmaceuticals (VRTX) Leads Hedge Fund Interest in Q3 20 - GuruFocus",
      "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNMXF1ZlBtRm5yQjZJZEJDYUFXaTMxZXFkM3NabGpPMnZveWNwOGlpNG84bWhsMVNhclljbTNhT3lTM0xuT0FuTFctMkVzU1VjaVVkTGFkN2hvcDk4dlNuSW9Oa2VkOU9XMEpmLTRBejEwM3pNYldtZno3VUIzS01zZFFFUkdCWnFncU5fYkdNWG1BdHROS0U3emFUaWs5Y0xrZkxsaE53?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipgFBVV95cUxNMXF1ZlBtRm5yQjZJZEJDYUFXaTMxZXFkM3NabGpPMnZveWNwOGlpNG84bWhsMVNhclljbTNhT3lTM0xuT0FuTFctMkVzU1VjaVVkTGFkN2hvcDk4dlNuSW9Oa2VkOU9XMEpmLTRBejEwM3pNYldtZno3VUIzS01zZFFFUkdCWnFncU5fYkdNWG1BdHROS0U3emFUaWs5Y0xrZkxsaE53?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX) Leads Hedge Fund Interest in Q3 20</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">GuruFocus</font>",
      "published": "2025-11-25T22:24:36+00:00",
      "source": "GuruFocus"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex’s new pain, blood disorder drugs miss Wall Street expectations - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5\" target=\"_blank\">Vertex’s new pain, blood disorder drugs miss Wall Street expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "VRTX Q3 Deep Dive: New Product Launches and Pipeline Progress Shape Outlook - Markets Financial Content",
      "link": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxNZ3AtR3VETG02RC1BVDZrWlJxNXd4YXM1Y1VueUkzTnUzOW9nLWpJNW0tcnhkcDh4UVBJT2hZeU9uSGgyX0VkWGRVVjdEZEZ6ci00dy1NWTU1OXBfbnlFY0Vycy1tSDVZeWlKdXAtMUNtUGR3U1dKMXlMc2pQMkNPYjV6ZGhYRmlsOHJVcHRKX2JaSWxNZHlTRkMtVzh6S1Zyc0x2eXh1V2ZsSEJNWWpHTFAxdGlpSFJoMU9QVG1TMDBOLTZEVDhvQWwzbHMwMm5TbEs4ZjBuMTZYcnNfSU9pZQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi4AFBVV95cUxNZ3AtR3VETG02RC1BVDZrWlJxNXd4YXM1Y1VueUkzTnUzOW9nLWpJNW0tcnhkcDh4UVBJT2hZeU9uSGgyX0VkWGRVVjdEZEZ6ci00dy1NWTU1OXBfbnlFY0Vycy1tSDVZeWlKdXAtMUNtUGR3U1dKMXlMc2pQMkNPYjV6ZGhYRmlsOHJVcHRKX2JaSWxNZHlTRkMtVzh6S1Zyc0x2eXh1V2ZsSEJNWWpHTFAxdGlpSFJoMU9QVG1TMDBOLTZEVDhvQWwzbHMwMm5TbEs4ZjBuMTZYcnNfSU9pZQ?oc=5\" target=\"_blank\">VRTX Q3 Deep Dive: New Product Launches and Pipeline Progress Shape Outlook</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Markets Financial Content</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "Markets Financial Content"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-11-26",
      "close": 432.1700134277344
    },
    "history": [
      {
        "date": "2025-11-18",
        "close": 435.5199890136719
      },
      {
        "date": "2025-11-19",
        "close": 421.0299987792969
      },
      {
        "date": "2025-11-20",
        "close": 422.32000732421875
      },
      {
        "date": "2025-11-21",
        "close": 426.760009765625
      },
      {
        "date": "2025-11-24",
        "close": 424.0
      },
      {
        "date": "2025-11-25",
        "close": 429.82000732421875
      },
      {
        "date": "2025-11-26",
        "close": 432.1700134277344
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}